Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma

(2012) Surasak Phuphanich et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors

(2012) Sofia Eberstål et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The efficacy of temozolomide for recurrent glioblastoma multiforme

(2012) Chao Chen et al.   EUROPEAN JOURNAL OF NEUROLOGY

PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells

(2012) Nataša Obermajer et al.   IMMUNOLOGICAL INVESTIGATIONS

The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

(2012) Dennis Lindau et al.   IMMUNOLOGY

A restricted cell population propagates glioblastoma growth after chemotherapy

(2012) Jian Chen et al.   NATURE

Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy

(2012) C. A. Crane et al.   NEURO-ONCOLOGY

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment

(2011) Christopher Jackson et al.   Clinical & Developmental Immunology

Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients

(2011) David A. Reardon et al.   JOURNAL OF NEURO-ONCOLOGY

Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme

(2011) C. E. Fadul et al.   NEURO-ONCOLOGY

T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies

(2010) Camilla A. Lindqvist et al.   IMMUNOLOGY

Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma

(2010) Florian Stockhammer et al.   JOURNAL OF NEURO-ONCOLOGY

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

(2010) Hilko Ardon et al.   JOURNAL OF NEURO-ONCOLOGY

Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway

(2010) J. Wei et al.   MOLECULAR CANCER THERAPEUTICS

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Side Population is Not Necessary or Sufficient for a Cancer Stem Cell Phenotype in Glioblastoma Multiforme

(2010) Kate W. R. Broadley et al.   STEM CELLS

Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapy

(2009) Jochen Tuettenberg et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors

(2009) Qinghai Liu et al.   JOURNAL OF NEURO-ONCOLOGY

Glioblastoma-Derived Mechanisms of Systemic Immunosuppression

(2009) Allen Waziri   NEUROSURGERY CLINICS OF NORTH AMERICA

Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma

(2008) Deirdre Toomey et al.   VACCINE